Nuclein is a molecular diagnostics company that builds handheld, point-of-care PCR testing systems. Its DASH Rapid PCR System is a compact, battery-capable instrument that runs disposable single-use cartridges and returns lab-quality PCR results in about 15 minutes with roughly one minute of hands-on time. The DASH SARS-CoV-2 & Flu A/B Test is FDA-cleared and CLIA-waived, so it can be run in urgent care, pediatric and primary care settings without sending samples to a central lab. Nuclein was founded in 2017 by Alan Blake and Dr. Richard Crockett and is based in Austin, Texas.